SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are infected. However, global testing rates are falling as we emerge from the acute health emergency and remain low in many low- and middle-income countries.